Peptide Sample Analysis Using EternityXT
Mar 16 2018 Read 906 Times
The peptide therapeutic market continues to develop fast where pharmaceutical companies focus in these types of compounds for large number of diseases. Chromatography plays an important role across the entire drug development cycle. Kromasil EternityXT, chemically stable merged inorganic/organic silica material for reversed phase chromatography, is a perfect material to be used from analysis to scale up of peptides.
With excellent mechanical and chemical stability, the Kromasil EternityXT materials offer first-rate separation power as well as loadability at low, medium and high pH. EternityXT columns are provided in 1.8 µm particles for UHPLC, 2.5 µm particles for both UHPLC and HPLC applications and finally 5 µm particles for HPLC and semipreparative chromatography. The C18 and C8 chemistries are also available in bulk for purification. The Kromasil EternityXT columns are based on patented technology, resulting from 30 years of expertise and used by chromatographers worldwide.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Articles - Determination of heroin in street drug samples with printable surface enhanced Raman scattering (P-SERS) - Advances in Protein Sample Preparation: Centrifugation i...
View all digital editions
Dec 14 2018 Kathmandu, Nepal
Jan 16 2019 Tokyo, Japan
Jan 28 2019 Dubai International Convention & Exhibition Centre
Jan 30 2019 Tokyo, Japan
Jan 31 2019 Paris, France